Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)249.50
  • Today's Change2.50 / 1.01%
  • Shares traded274.85k
  • 1 Year change-10.57%
  • Beta0.6605
Data delayed at least 20 minutes, as of Nov 15 2019 16:35 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.

  • Revenue in GBP (TTM)103.69m
  • Net income in GBP20.57m
  • Incorporated1993
  • Employees654.00
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 160 686 3500
  • Fax+44 160 686 3600
  • Websitehttp://www.admedsol.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AMS:LSE since
announced
Transaction
value
Sealantis LtdDeal completed31 Jan 201931 Jan 2019Deal completed-14.26%25.00m
Data delayed at least 20 minutes, as of Nov 15 2019 16:35 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Indivior PLC689.20m165.13m301.66m1.02k1.911.541.650.43770.21630.21630.89980.26740.56531.753.84673,044.2013.5519.0126.5458.1685.0489.9523.9619.151.97--0.53689.09-8.05-3.74273.97-11.0068.71--
Silence Therapeutics plc0.00-17.93m308.65m45.00--10.47-----0.2530-0.25300.000.37640.00----0.00-46.23-19.56-50.43-20.44-------5,768.04----0.00---100.00---1,037.89--9.39--
Alliance Pharma plc129.76m21.67m389.35m210.0018.071.4916.543.000.0410.0410.24530.49690.32142.946.26617,904.805.376.627.007.8762.8358.7516.7021.100.46598.460.267231.8016.3021.16-36.3313.88-21.5810.02
Oxford BioMedica plc63.59m-7.81m429.97m377.00--5.36--6.76-0.1146-0.11460.91811.040.5536.023.04168,684.30-6.79-14.68-9.41-19.7861.6460.85-12.28-24.622.12-1.070.0955--77.6565.52183.63--61.04--
Vectura Group PLC172.30m-78.00m520.17m453.00--1.091,040.343.02-0.1267-0.12670.280.77980.27392.924.53380,353.20-12.40---13.67--56.99---45.27--2.41--0.017--8.45---1.03------
Advanced Medical Solutions Group plc103.69m20.57m535.90m654.0026.232.9321.025.170.09510.09510.47940.85110.51462.784.92158,548.9010.2112.4310.9613.6360.4059.2819.8420.596.08106.250.049712.005.8711.5111.6914.6218.1617.08
Puretech Health PLC15.63m-5.67m623.85m225.00--2.28--39.92-0.0228-0.02280.05430.96110.0383--4.3269,455.51-13.04-28.57-17.99-45.76-----340.74-865.69----0.2374--718.4619.53-264.91--50.17--
Data as of Nov 15 2019. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

48.91%Per cent of shares held by top holders
HolderShares% Held
Octopus Investments Ltd.as of 08 Apr 201922.21m10.34%
AXA Investment Managers UK Ltd.as of 08 Apr 201917.22m8.02%
Hargreave Hale Ltd.as of 08 Apr 201914.37m6.69%
Investec Wealth & Investment Ltd.as of 08 Apr 201910.15m4.73%
Groupama Asset Management SAas of 08 Apr 20199.29m4.33%
Aviva Investors Global Services Ltd.as of 08 Apr 20198.43m3.93%
BlackRock Investment Management (UK) Ltd.as of 29 Oct 20196.86m3.19%
Kames Capital Plcas of 08 Apr 20196.56m3.06%
CA Indosuez Wealth (Private Banking Europe)as of 02 Aug 20195.30m2.47%
Schroder Investment Management Ltd.as of 02 Aug 20194.62m2.15%
More ▼
Data from 28 Jun 2019 - 31 Oct 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.